Home
About
Overview
Sharing Data
ORCID
Help
History (86)
Analysis of Gal4-directed transcription activation using Tra1 mutants selectively defective for interaction with Gal4.
Sodium Chloride Symporter Inhibitors
2-Acetylaminofluorene
Dimethylallyltranstransferase
Biosimilars: a regulatory perspective from America.
See All 86 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biosimilars: a regulatory perspective from America.
Kay J. Biosimilars: a regulatory perspective from America. Arthritis Res Ther. 2011 May 12; 13(3):112.
View in:
PubMed
subject areas
Animals
Antirheumatic Agents
China
Drug Approval
Drug Industry
Drugs, Generic
Humans
Rheumatic Diseases
United States
authors with profiles
Jonathan Kay MD